The ROE as of December 2024 (TTM) for MAIA Biotechnology, Inc. (MAIA) is 20.47%

According to MAIA Biotechnology, Inc.’s latest financial reports and current stock price. The company's current ROE is 20.47%. This represents a change of -5153.21% compared to the average of -405.05% of the last 4 quarters.

MAIA Biotechnology, Inc. (MAIA) Historical ROE (quarterly & annually)

How has MAIA ROE performed in the past?

The mean historical ROE of MAIA Biotechnology, Inc. over the last ten years is -103.10%. The current 20.47% ROE has changed -19952.61% with respect to the historical average. Over the past ten years (40 quarters), MAIA's ROE was at its highest in in the March 2024 quarter at 139.94%. The ROE was at its lowest in in the December 2023 quarter at -1310.27%.

MAIA Biotechnology, Inc. (MAIA) ROE by Quarter and Year

Discovering the peaks and valleys of MAIA Biotechnology, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

MAIA Biotechnology, Inc. (MAIA) Average ROE

How has MAIA ROE performed in the past?

The current ROE of MAIA Biotechnology, Inc. (MAIA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

MAIA Biotechnology, Inc. (MAIA) ROE vs. Peers

How is MAIA’s ROE compared to its peers?

MAIA Biotechnology, Inc.’s ROE is greater than Lineage Cell Therapeutics, Inc. (-29.91%), greater than Armata Pharmaceuticals, Inc. (89.12%), greater than Frequency Therapeutics, Inc. (-58.14%), greater than Portage Biotech Inc. (-673.96%), greater than AgeX Therapeutics, Inc. (172.71%), greater than Larimar Therapeutics, Inc. (-35.87%), greater than Graphite Bio, Inc. (-57.96%), greater than Lyra Therapeutics, Inc. (-178.68%), greater than Genelux Corporation (-105.05%), greater than Comera Life Sciences Holdings, Inc. (67.46%), greater than Dyadic International, Inc. (-149.17%), greater than Cingulate Inc. (-113174.53%), greater than Monopar Therapeutics Inc. (-21731.73%), greater than Transgene SA (-295.34%), greater than Eupraxia Pharmaceuticals Inc. (-182.55%), greater than Champions Oncology, Inc. (66.22%), greater than Lumos Pharma, Inc. (-233.03%), greater than Roivant Sciences Ltd. (83.39%), greater than Field Trip Health & Wellness Ltd. (-109.89%), greater than Telix Pharmaceuticals Limited (11.29%), greater than Nautilus Biotechnology, Inc. (-28.85%),

Build a custom stock screener for MAIA Biotechnology, Inc. (MAIA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MAIA Biotechnology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

MAIA Biotechnology, Inc. (MAIA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like MAIA Biotechnology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.